Literature DB >> 8959646

Immunotoxic effect of low dose cisplatin in mice.

Y Kouchi1, Y Maeda, A Ohuchida, M Ohsawa.   

Abstract

The immunosuppressive effects of cisplatin at relatively low doses were investigated in CD-1 mice. Mice were injected intraperitoneally with 8, 40 and 200 micrograms/kg cisplatin for 10 days. A decrease in body and thymus weights was observed at 200 micrograms/kg. Though there were no dose-related effects on the IgM antibody response to sheep erythrocytes, a statistically significant reduction of the contact hypersensitivity response (CHR) was seen at 200 micrograms/kg. In vivo and in vitro effects of cisplatin on T- and B-lymphocyte function were assessed by proliferative response to concanavalin A and lipopolysaccharide, respectively. Cisplatin inhibited splenic T-lymphocyte function more than splenic B-lymphocyte function. These data indicate that a relatively low dose of cisplatin induce immunosuppressive effects in mice with a greater effect on T-lymphocytes than the B-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8959646     DOI: 10.2131/jts.21.4_227

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  4 in total

1.  Protective effect of Echinacea purpurea (Immulant) against cisplatin-induced immunotoxicity in rats.

Authors:  Abdelazeem Ali Khalaf; Shaymaa Hussein; Adel Fathy Tohamy; Sherif Marouf; Hanan Dawood Yassa; Amr Reda Zaki; Anupam Bishayee
Journal:  Daru       Date:  2019-05-27       Impact factor: 3.117

2.  In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells.

Authors:  Milos Arsenijevic; Marija Milovanovic; Snezana Jovanovic; Natalija Arsenijevic; Bojana Simovic Markovic; Marina Gazdic; Vladislav Volarevic
Journal:  J Biol Inorg Chem       Date:  2017-04-18       Impact factor: 3.358

3.  Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.

Authors:  Woo Sik Kim; Hongmin Kim; Kee Woong Kwon; Sin-Hyeog Im; Bo Ryeong Lee; Sang-Jun Ha; Sung Jae Shin
Journal:  Oncotarget       Date:  2016-06-07

4.  Antiemetic and Myeloprotective Effects of Rhus verniciflua Stoke in a Cisplatin-Induced Rat Model.

Authors:  Hyo-Seon Kim; Hyeong-Geug Kim; Hwi-Jin Im; Jin-Seok Lee; Sung-Bae Lee; Won-Yong Kim; Hye-Won Lee; Sam-Keun Lee; Chang Kyu Byun; Chang-Gue Son
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-08       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.